Akebia Therapeutics
Presence
Akebia Therapeutics is one of the...
Akebia Therapeutics is a company listed under the stock ticker AKBA (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Akebia Therapeutics
- John Butler, President and Chief Executive Officer, Director
- Michael Rogers, Director
- Myles Wolf, Director
Popular executive movements at Akebia Therapeutics
- Ron Frieson has joined the company as Director (posted on November 1 2021).
Create an alert
to follow the executive moves at Akebia Therapeutics.
Biotechnology
Akebia Therapeutics has 2,050 competitors including Neptune Wellness Solutions (Canada), Inivata (United States (USA)) and Biogroup-LCD (France).
Popular M&A news in Biotechnology
- PicnicHealth has just announced a $60 Million fundraising. (posted on July 1 2022).
- Visby Medical becomes a unicorn with its fundraising of $100 Million. (posted on July 1 2022).
- ReCode Therapeutics has just announced a $200 Million fundraising. (posted on June 30 2022).
Popular contacts in Biotechnology
News
Press releases by Akebia Therapeutics
- Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka | Akebia Therapeutics
- Akebia Therapeutics to Present at Jefferies Healthcare Conference | Akebia Therapeutics
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Akebia Therapeutics
- Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference | Akebia Therapeutics
- Press Releases | Akebia Therapeutics
- Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update | Akebia Therapeutics
- Akebia Therapeutics to Report First Quarter Financial Results | Akebia Therapeutics
- Akebia to Present Global Phase 3 Vadadustat Data at American Society of Nephrology Kidney Week 2020 Reimagined | Akebia Therapeutics
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Akebia Therapeutics
- Akebia Therapeutics Announces September 2020 Investor Conference Schedule | Akebia Therapeutics
- View more press releases Close
Social media about Akebia Therapeutics
- Akebia Therapeutics on Wikipedia, Google News & Yahoo Finance
- Akebia Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Butler 
Call Akebia Therapeutics at +1 617...
